Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2016 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (196)	5/28/2016 3:11:03 AM
From: Robohogs	Respond to of 311

I was just looking through a list of bios and it has really been hit or miss since March 31. The list I was looking at was 50-60 names and on average was up low to mid teens. But man, if you hit the wrong 5 in a row you might have expected doen 5-10%. BUT 5 down at 7% each get swamped by one IMMU up almost 90%. In one fell swoop, you go from down 7% to up 9%. Add a CDXS, a RTRX, maybe a MDGN. Maybe an ARIA. A MDVN. Definitely DEPO. But half the stocks have to lift the rest, more so than usual. This is good as mkt differentiating again. But not sure mkt being smart about it. Some of the product guys still crashing (AMAG, although tecent up ticks) while DEPO, EGRX and RTRX behave very well. A few weeks ago, most of these were on still crashing list. Ceazy mkt.